Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics

被引:5
|
作者
Fukunishi, Yoshifumi [1 ,2 ]
Mashimo, Tadaaki [2 ,3 ]
Misoo, Kiyotaka [2 ,3 ]
Wakabayashi, Yoshinori [4 ]
Miyaki, Toshiaki [5 ]
Ohta, Seiji [6 ]
Nakamura, Mayu [6 ]
Ikeda, Kazuyoshi [6 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[2] Technol Res Assoc Next Generat Nat Prod Chem, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[3] IMSBIO Co Ltd, Toshima Ku, Owl Tower,4-21-1 Higashi Ikebukuro, Tokyo 1700013, Japan
[4] BY HEX LLP, Suginami Ku, 1-19-14 Shimizu, Tokyo 1670033, Japan
[5] DiscoveResource Inc, Minato Ku, 2-4-15 Minami Aoyama, Tokyo 1070062, Japan
[6] LEVEL FIVE Co Ltd, Minato Ku, 21F,Shiodome Shibarikyu Bldg 1-2-3, Tokyo 1050022, Japan
关键词
Computer-aided drug design; Synthetic accessibility; Cloud computing; GPU computing; Virtual screening; Molecular dynamics simulation; MOLECULAR-DYNAMICS SIMULATIONS; CHEMISTRY; COMPLEXITY; CLOUD; ZINC;
D O I
10.2174/1381612822666160414142547
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design.
引用
收藏
页码:3555 / 3568
页数:14
相关论文
共 50 条
  • [41] Computer-aided drug design at Boehringer Ingelheim
    Ingo Muegge
    Andreas Bergner
    Jan M. Kriegl
    Journal of Computer-Aided Molecular Design, 2017, 31 : 275 - 285
  • [42] TOPICS IN COMPUTER-AIDED DESIGN .2. SYNTHESIS OF OPTIMAL HEAT-EXCHANGER NETWORKS BY TREE SEARCHING ALGORITHMS
    PHO, TK
    LAPIDUS, L
    AICHE JOURNAL, 1973, 19 (06) : 1182 - 1189
  • [43] Drug Repositioning Using Computer-aided Drug Design (CADD)
    Rawat, Sona
    Subramaniam, Kanmani
    Subramanian, Selva Kumar
    Subbarayan, Saravanan
    Dhanabalan, Subramanian
    Chidambaram, Sashik Kumar Madurai
    Stalin, Balasubramaniam
    Roy, Arpita
    Nagaprasad, Nagaraj
    Aruna, Mahalingam
    Tesfaye, Jule Leta
    Badassa, Bayissa
    Krishnaraj, Ramaswamy
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (03) : 301 - 312
  • [44] Role of computer-aided drug design in modern drug discovery
    Stephani Joy Y. Macalino
    Vijayakumar Gosu
    Sunhye Hong
    Sun Choi
    Archives of Pharmacal Research, 2015, 38 : 1686 - 1701
  • [45] Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
    Niazi, Sarfaraz K.
    Mariam, Zamara
    PHARMACEUTICALS, 2024, 17 (01)
  • [46] Role of computer-aided drug design in modern drug discovery
    Macalino, Stephani Joy Y.
    Gosu, Vijayakumar
    Hong, Sunhye
    Choi, Sun
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (09) : 1686 - 1701
  • [47] A Review of Deep Learning in Computer-Aided Drug Design
    Chang, Chih-Hung
    Hung, Che-Lun
    Tang, Chuan Yi
    2019 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2019, : 1856 - 1861
  • [48] The future of force fields in computer-aided drug design
    Cole, Daniel J.
    Horton, Joshua T.
    Nelson, Lauren
    Kurdekar, Vadiraj
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (18) : 2359 - 2363
  • [49] Computer-aided retrometabolic drug design: soft drugs
    Buchwald, Peter
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (07) : 923 - 933
  • [50] Computer-aided drug design: the next 20 years
    Van Drie, John H.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (10-11) : 591 - 601